| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.003 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.003 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.004 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.005 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.005 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.005 |